Skip to the page

Data / Form D filings / Jellatech, Inc.

Jellatech, Inc.: Form D filings

Jellatech, Inc., a biotechnology company in Raleigh, NC, filed 7 Form D notices with the SEC in 2023. The latest, on September 7, 2023, reports $725,000 sold of a $725,000 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
617 HUTTON STREET, SUITE 112, Raleigh, NC, 27606
Phone
(800) 246-2677
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1966378

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 7, 2023New notice$725,000$725,0002Feb 10, 2021sec.gov
Sep 7, 2023New notice$975,000$975,0004Nov 30, 2020sec.gov
Sep 7, 2023New notice$3,000,000$165,000$2,835,0004Jan 25, 2023sec.gov
Sep 7, 2023New notice$75,000$75,0001Jul 13, 2022sec.gov
Sep 7, 2023New notice$926,000$926,0005Nov 17, 2021sec.gov
Sep 7, 2023New notice$3,500,000$3,500,0008Aug 23, 2023sec.gov
Sep 7, 2023New notice$100,000$100,0001Oct 30, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ryan BethencourtDirector
Stephanie MichelsenExecutive Officer, Director
Peter AndersenDirector

Other biotechnology companies in North Carolina that filed recently

Every Form D from the week of Sep 4, 2023 · All recent filings in North Carolina · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Jellatech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.